Cardiac metastasis from a Pancoast tumour presenting with ST-segment elevation and 2:1 atrioventricular block: a case
Qing Yi Fang1, Vincenzo Somma1, Paul B Sparks1
1Department of Cardiology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia.
Insights
Cardiac metastases rarely cause 2:1 atrioventricular (AV) block. This case report details a patient with a Pancoast tumor who developed this rare condition, emphasizing the role of imaging in diagnosis and the challenges of pacemaker implantation.
Area of Science:
- Cardiology
- Oncology
- Medical Imaging
Background:
- Cardiac metastases are more prevalent than primary cardiac tumors.
- Clinical presentations vary, including pericardial effusion, valvular dysfunction, and conduction disturbances.
- 2:1 atrioventricular (AV) block is an uncommon manifestation of cardiac metastases.
Background:
Cardiac metastases are significantly more common than primary cardiac tumours. Their clinical presentation varies depending on tumour size, location, and degree of myocardial or pericardial infiltration. Common manifestations include pericardial effusion, valvular dysfunction due to inflow or outflow obstruction, and conduction disturbances. 2:1 atrioventricular (AV) block secondary to cardiac metastases is rare.
Case Summary:
We report a case of a 69-year-old man with a Pancoast tumour who presented with hyperacute ST-segment elevation and 2:1 AV block. Transthoracic echocardiography (TTE) and positron emission tomography (PET) revealed intracardiac metastases. A permanent dual-chamber pacemaker was implanted for symptomatic 2:1 AV block. The patient died from advanced malignancy shortly after device implantation.
Discussion:
This case highlights 2:1 AV block as an uncommon manifestation of cardiac metastases. Multimodality imaging, particularly TTE, cardiac magnetic resonance imaging, and cardiac PET, plays a pivotal role in timely diagnosis. Permanent pacemaker implantation in such cases is a challenge in terms of clinical utility and palliative care. Decisions regarding permanent pacing should be shared between the patient and clinicians, incorporating balance between clinical indications, patient's comorbidities, prognosis, and preferences.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

